By Donna Domino, Features Editor
February 10, 2014 — The type of cancer stem cells, rather than the number, is a better predictor of the survival of patients with human papillomavirus (HPV)-related head and neck cancer, according to a new study in Cancer (December 30, 2013). Previously, researchers thought patients with HPV-positive tumors had better outcomes because their tumors had fewer cancer stem cells than HPV-negative tumors. Ohio researchers discovered just the opposite, however.
Read complete article about cancer stem cell types, including details of the retrospective study by researchers from Ohio State University at Dr.Bicuspid
(Visited 10 times, 1 visits today)